Silver Palm Capital Healthcare Partners

The firm targets buyouts, management buyouts, recapitalizations, restructurings, turnarounds, and succession-driven transactions, per its own description of its strategy. Each deal is pursued on a standalone, deal-by-deal basis consistent with an independent sponsor model, rather than out of a committed fund.

Independent sponsors typically source through long-standing relationships with founders, operators, intermediaries, and sector-specific networks. Silver Palm's website indicates it partners directly with founders, owners, operators, and entrepreneurs, suggesting a relationship-driven origination model rather than competitive auction participation.

No. The firm identifies as an independent sponsor, meaning it raises equity capital for each transaction individually from a network of co-investors, family offices, and high-net-worth individuals, rather than deploying from a blind-pool committed fund with a fixed investment period.

The firm states it primarily focuses on lower middle-market businesses in the healthcare services sector based in the United States. The firm has not publicly specified a revenue or EBITDA range, which is common for independent sponsors whose deal size flexibility is tied to specific co-investor appetite rather than a fund mandate.

No public record or disclosure indicates any affiliation with a larger financial institution, family office, or permanent capital base. The firm operates as a standalone entity registered in the United States and does not list any parent company or umbrella organization.